NGRDX
Price
$32.76
Change
-$0.03 (-0.09%)
Updated
Aug 15 closing price
Net Assets
2.63B
RGACX
Price
$82.10
Change
-$0.06 (-0.07%)
Updated
Aug 15 closing price
Net Assets
329.22B
Interact to see
Advertisement

NGRDX vs RGACX

Header iconNGRDX vs RGACX Comparison
Open Charts NGRDX vs RGACXBanner chart's image
Neuberger Berman Large Cap Growth R6
Price$32.76
Change-$0.03 (-0.09%)
VolumeN/A
Net Assets2.63B
American Funds Growth Fund of Amer R3
Price$82.10
Change-$0.06 (-0.07%)
VolumeN/A
Net Assets329.22B
NGRDX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NGRDX vs. RGACX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGRDX is a StrongBuy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. NGRDX (2.63B). NGRDX pays higher dividends than RGACX: NGRDX (0.24) vs RGACX (0.07). NGRDX was incepted earlier than RGACX: NGRDX (6 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than NGRDX (0.60). NGRDX is a more actively managed with annual turnover of: 30.00 vs. RGACX (25.00). NGRDX has a lower initial minimum investment than RGACX: NGRDX (0) vs RGACX (250). RGACX (14.08) and NGRDX (13.80) have marching annual gain over last year. NGRDX return over 5 years is better than : 49.92 vs. RGACX (41.95).
NGRDXRGACXNGRDX / RGACX
Total Expense Ratio0.560.9460%
Annual Report Gross Expense Ratio0.600.9464%
Fund Existence6 years23 years-
Gain YTD11.84714.04484%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.63B329B1%
Annual Yield % from dividends0.240.07330%
Returns for 1 year13.8014.0898%
Returns for 3 years37.8041.1992%
Returns for 5 years49.9241.95119%
Returns for 10 yearsN/A83.68-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOFX45.180.99
+2.24%
Patient Opportunity FI
TVRCX15.63-0.01
-0.06%
NAA Allocation C
CSGEX14.07-0.01
-0.07%
BlackRock Advantage Small Cap Gr Inv A
AMRGX7.11-0.01
-0.14%
American Growth One D
MIRTX34.66-0.11
-0.32%
MFS Massachusetts Investors Tr R2